Ken Fisher acquired 14.1 Million Novo Nordisk - ADR shares worth $1.82 Billion. That's 0.91% of their equity portfolio (28th largest holding). The first Novo Nordisk - ADR trade was made in Q1 2013. Since then Ken Fisher bought shares 22 more times and sold shares on 21 occasions. The stake costed the investor $621 Million, netting the investor a gain of 193% so far.